Cargando…

Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer

Detalles Bibliográficos
Autor principal: Intelligence and Neuroscience, Computational
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550462/
https://www.ncbi.nlm.nih.gov/pubmed/37800020
http://dx.doi.org/10.1155/2023/9859267
_version_ 1785115544767168512
author Intelligence and Neuroscience, Computational
author_facet Intelligence and Neuroscience, Computational
author_sort Intelligence and Neuroscience, Computational
collection PubMed
description
format Online
Article
Text
id pubmed-10550462
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105504622023-10-05 Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer Intelligence and Neuroscience, Computational Comput Intell Neurosci Retraction Hindawi 2023-09-27 /pmc/articles/PMC10550462/ /pubmed/37800020 http://dx.doi.org/10.1155/2023/9859267 Text en Copyright © 2023 Computational Intelligence and Neuroscience. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Intelligence and Neuroscience, Computational
Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer
title Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer
title_full Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer
title_fullStr Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer
title_full_unstemmed Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer
title_short Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer
title_sort retracted: effects of gemcitabine and oxaliplatin combined with apatinib on immune function and levels of sil-2r and sicam-1 in patients with gallbladder cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550462/
https://www.ncbi.nlm.nih.gov/pubmed/37800020
http://dx.doi.org/10.1155/2023/9859267
work_keys_str_mv AT intelligenceandneurosciencecomputational retractedeffectsofgemcitabineandoxaliplatincombinedwithapatinibonimmunefunctionandlevelsofsil2randsicam1inpatientswithgallbladdercancer